Experts in interventional cardiology, medical billing unite to discuss Shockwave Medical’s IVL technology

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Intravascular lithotripsy in action. Image courtesy of Shockwave Medical, a part of Johnson & Johnson MedTech.

Intravascular lithotripsy has quickly emerged as one of healthcare’s most in-demand technologies. Now Shockwave Medical, part of Johnson & Johnson MedTech, is co-hosting a webinar designed to teach coding and billing specialists how to code appropriately for peripheral and coronary IVL procedures. 

CVB 40 Under 40

Nominate leaders for the Cardiovascular Business Forty Under 40 Awards

The Cardiovascular Business Forty Under 40 Awards honor the nation's top cardiology professionals under 40 (born on or after April 1, 1985), recognizing their achievements, innovation and leadership.